The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders

被引：0
|
作者：
Seithikurippu R Pandi-Perumal
Ilya Trakht
D Warren Spence
Venkataramanujan Srinivasan
Yaron Dagan
Daniel P Cardinali
机构：
[1] College of Physicians and Surgeons at Columbia University,SR Pandi
[2] New York,Perumal is the President and Chief Executive Officer of Somnogen Inc. and I Trakht is an Assistant Professor in the Division of Clinical Pharmacology and Experimental Therapeutics, Department of Medicine
[3] NY,V Srinivasan is an Associate Professor in the Department of Physiology
[4] USA.,Y Dagan is a Senior Emergency Physician and Head of the Medical Education Department in the Faculty of Medicine at Tel Aviv University
[5] DW Spence is a PhD student at the University of Toronto,undefined
[6] Toronto,undefined
[7] ON,undefined
[8] Canada.,undefined
[9] School of Medical Sciences at University Sains Malaysia,undefined
[10] Kota Bharu,undefined
[11] Kelantan,undefined
[12] Malaysia.,undefined
[13] Tel Aviv,undefined
[14] Israel.,undefined
[15] DP Cardinali is Professor of Physiology and Director of the Neuroscience Laboratory in the Faculty of Medicine at University of Buenos Aires,undefined
[16] Buenos Aires,undefined
[17] Argentina.,undefined
来源：
Nature Clinical Practice Neurology | 2008年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Desynchronization of circadian rhythms is a common occurrence in individuals presenting with sleep disorders. In this Review, Pandi-Perumal et al. highlight the roles of light and endogenous melatonin in the synchronization of sleep–wake rhythms and rest–activity cycles with the light–dark cycle, and they discuss how light therapy and exogenous melatonin might be used to treat circadian rhythm sleep disorders.
引用
收藏
页码：436 / 447
页数：11
相关论文
共 50 条
  • [11] Treatment of circadian rhythm disorders - Melatonin
    Arendt, J
    Deacon, S
    CHRONOBIOLOGY INTERNATIONAL, 1997, 14 (02) : 185 - 204
  • [12] Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders
    Hardeland, Ruediger
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (07) : 691 - 701
  • [13] Melatonin for the treatment of disorders in circadian rhythm and sleep: Could it form a basis for medication?
    Nir, I
    RECEPTORS & CHANNELS, 2003, 9 (06): : 379 - 385
  • [14] Circadian rhythm sleep disorders - Pathophysiology and potential approaches to management
    Zisapel, N
    CNS DRUGS, 2001, 15 (04) : 311 - 328
  • [15] The role of the thalamus in sleep, pineal melatonin production, and circadian rhythm sleep disorders
    Jan, James E.
    Reiter, Russel J.
    Wasdell, Michael B.
    Bax, Martin
    JOURNAL OF PINEAL RESEARCH, 2009, 46 (01) : 1 - 7
  • [16] Why the dim light melatonin onset (DLMO) should be measured before treatment of patients with circadian rhythm sleep disorders
    Keijzer, Henry
    Smits, Marcel G.
    Duffy, Jeanne F.
    Curfs, Leopold M. G.
    SLEEP MEDICINE REVIEWS, 2014, 18 (04) : 333 - 339
  • [17] Treatment of human circadian rhythm sleep disorders
    Ohta, T
    Hayakawa, T
    Kayukawa, Y
    Okada, T
    SLEEP-WAKE DISORDERS, 1997, : 53 - 60
  • [18] ACTION OF LIGHT ON THE HUMAN CIRCADIAN PACEMAKER - TREATMENT OF PATIENTS WITH CIRCADIAN-RHYTHM SLEEP DISORDERS
    CZEISLER, CA
    KRONAUER, RE
    JOHNSON, MP
    ALLAN, JS
    JOHNSON, TS
    DUMONT, M
    SLEEP 88, 1989, : 42 - 47
  • [19] Circadian rhythm sleep-wake disorders: Pathophysiology, comorbidity, and management
    Kitajima, Tsuyoshi
    Kuriyama, Kenichi
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [20] Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders
    Williams, Wilbur P. , III
    McLin, Dewey E., III
    Dressman, Marlene A.
    Neubauer, David N.
    PHARMACOTHERAPY, 2016, 36 (09): : 1028 - 1041
12345